GE HealthCare Technologies (GEHC) Liabilities and Shareholders Equity (2022 - 2026)
GE HealthCare Technologies (GEHC) reported Liabilities and Shareholders Equity of $37.1 billion for Q1 2026, up 10.54% on a YoY basis from $33.6 billion in Q1 2025, and up 0.59% quarter-over-quarter from $36.9 billion in Q4 2025.
GE HealthCare Technologies (GEHC) Liabilities and Shareholders Equity (2022 - 2026) Analysis & Trends
GE HealthCare Technologies has reported Liabilities and Shareholders Equity for 5 years, with the latest figure at $37.1 billion in Q1 2026.
- For the quarter ending Q1 2026, Liabilities and Shareholders Equity rose 10.54% year-over-year to $37.1 billion; the trailing twelve-month figure through Mar 2026 stood at $145.7 billion (up 10.03% YoY), and the FY2025 full-year result was $36.9 billion, up 11.54% from the prior year.
- Liabilities and Shareholders Equity for Q1 2026 stood at $37.1 billion, up from $36.9 billion in the prior quarter.
- The five-year high for Liabilities and Shareholders Equity was $37.1 billion in Q1 2026, with the low at $27.5 billion in Q4 2022.
- Historically, Liabilities and Shareholders Equity has averaged $33.4 billion across 5 years, with a median of $32.9 billion in 2023.
- Annual changes were most pronounced in 2023 — Liabilities and Shareholders Equity increased 17.85% — and 2024, when it dropped 1.42%.
- GE HealthCare Technologies' Liabilities and Shareholders Equity stood at $27.5 billion in 2022, then advanced by 17.85% to $32.5 billion in 2023, then advanced by 1.96% to $33.1 billion in 2024, then rose by 11.54% to $36.9 billion in 2025, then advanced by 0.59% to $37.1 billion in 2026.
- The last three Liabilities and Shareholders Equity figures came in at $37.1 billion (Q1 2026), $36.9 billion (Q4 2025), and $36.1 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 46.29 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 91.49 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 13.32 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 31.92 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 6.63 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 37.13 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 10.74 Bn |
| 10 | Zimmer Biomet Holdings | 17.18 Bn | 16.77 Bn | 1.51 Bn | 22.72 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 37.13 Bn |
| Dec 31, 2025 | 36.91 Bn |
| Sep 30, 2025 | 36.13 Bn |
| Jun 30, 2025 | 35.50 Bn |
| Mar 31, 2025 | 33.59 Bn |
| Dec 31, 2024 | 33.09 Bn |
| Sep 30, 2024 | 33.86 Bn |
| Jun 30, 2024 | 31.85 Bn |
| Mar 31, 2024 | 32.21 Bn |
| Dec 31, 2023 | 32.45 Bn |
| Sep 30, 2023 | 32.38 Bn |
| Jun 30, 2023 | 32.31 Bn |
| Mar 31, 2023 | 32.64 Bn |
| Dec 31, 2022 | 27.54 Bn |